Burden of treatment for chronic illness: A concept analysis and review of the literature

Health Expectations

Volumn 18, Issue 3, 2015, Pages 312-324

  Sav, Adem ^a   King, Michelle A ^b   Whitty, Jennifer A ^c   Kendall, Elizabeth ^a   Mcmillan, Sara S ^a   Kelly, Fiona ^c,d   Hunter, Beth ^a   Wheeler, Amanda J ^a,e  

^a GRIFFITH UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Chronic illness; Concept analysis; Health professional; Medication burden; Treatment burden

Indexed keywords

CHRONIC DISEASE; COST OF ILLNESS; HUMAN; THEORETICAL MODEL;

CHRONIC DISEASE; COST OF ILLNESS; HUMANS; MODELS, THEORETICAL;

EID: 84928770943     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12046     Document Type: Article

References (51)

1. Alwan A, Armstrong T, Cowan M, Riley L. Noncommunicable Diseases Country Profiles 2011. Geneva, Switzerland: World Health Organization, 2011.
2. Mathers CD, Vos ET, Stevenson CE, Begg SJ. The burden of disease and injury in Australia. Bulletin of the World Health Organization, 2001; 79: 1076-1084.
3. Gapstur RL. Symptom burden: a concept analysis and implications for oncology nurses. Oncology Nursing Forum, 2007; 34: 673-680.
4. Australian Institute of Health and Welfare. Australia's Health, 2010. Australia's Health Series No. 12. Cat. No. AUS 122. In: Australian Institute of Health and Welfare, ed. Canberra: Commonwealth of Australia, 2010.
5. Anderson RT, Skovlund SE, Marrero D et al. Development and validation of the insulin treatment satisfaction questionnaire. Clinicial Therapeutics, 2004; 26: 565-578.
6. Béchetoille A, Arnould B, Bron A et al. Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL © 36-item questionnaire. Acta Ophthalmologica, 2008; 86: 71-80.
7. Brod M, Hammer M, Kragh N, Lessard S, Bushnell DM. Development and validation of the treatment related impact measure of weight (TRIM-weight). Health and Quality of Life Outcomes, 2010; 8: 19-30.
8. Brod M, Valensi P, Shaban JA, Bushnell DM, Christensen TL. Patient treatment satisfaction after switching to NovoMixReg. 30 (BIAsp 30) in the IMPROVETM study: an analysis of the influence of prior and current treatment factors. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 2010; 19: 1285-1293.
9. Campbell JL, Kiebert GM, Partridge MR. Development of the satisfaction with inhaled asthma treatment questionnaire. European Respiratory Journal, 2003; 22: 127-134.
10. Chen H, Cisternas MG, Katz PP et al. Evaluating quality of life in patients with asthma and rhinitis: English adaptation of the Rhinasthma Questionnaire. Annals of Allergy, Asthma, & Immunology, 2011; 106: 110-118.
11. Henry B, Aussage P, Grosskopf C, Goehrs JM. Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 2003; 12: 63-76.
12. Modi AC, Quittner AL. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. Journal of Pediatric Psychology, 2003; 28: 535-546.
13. Bernhard J, Maibach R, Thurlimann B, Sessa C, Aapro MS, Swiss Group for Clinical Cancer Research. Patients' estimation of overall treatment burden: why not ask the obvious? Journal of Clinical Oncology, 2002; 20: 65-72.
14. Oude Elberink JNG, van der Heide S, Guyatt GH, Dubois AEJ. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. Journal of Allergy and Clinical Immunology, 2006; 118: 699-704.
15. Wilcox AR, Dragnev MCC, Darcey CJ, Siegel CA. A new tool to measure the burden of Crohn's disease and its treatment: do patient and physician perceptions match? Inflammatory Bowel Diseases, 2010; 16: 645-650.
16. Ribi K, Bernhard J, Bohme C et al. Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. Supportive Care in Cancer, 2007; 15: 1349-1356.
17. Bailie GR, Cardone KE, Grabe DW, Hoy CD, Manley HJ, Meola S. Quantifying home medication regimen changes and quality of life in patients receiving nocturnal home hemodialysis. Hemodialysis International, 2011; 15: 234-242.
18. Corona J, Matsumoto H, Roye DP, Vitale MG. Measuring quality of life in children with early onset scoliosis: development and initial validation of the early onset scoliosis questionnaire. Journal of Pediatric Orthopedics, 2011; 31: 180-185.
19. Gallacher K, May CR, Montori VM, Mair FS. Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory. Annals of Family Medicine, 2011; 9: 235-243.
20. Walker LO, Avant KC. Strategies for Theory Construction in Nursing. Upper Saddle River, NJ: Pearson Prentice Hall, 2005.
21. Rodgers BL. Concepts, analysis and the development of nursing knowledge: the evolutionary cycle. Journal of Advanced Nursing, 1989; 14: 330-335.
22. Rodgers BL, ed. Concept Analysis: An Evolutionary View. Philadelphia, PA: Saunders, 2000.
23. Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Quality of Life Research, 2007; 16: 1053-1063.
24. Graves MM, Adams CD, Bender JA, Simons S, Portnoy JM. Volitional nonadherence in pediatric asthma: parental report of motivating factors. Current Allergy and Asthma Reports, 2007; 7: 427-432.
25. Fiese BH, Wamboldt FS, Anbar RD. Family asthma management routines: connections to medical adherence and quality of life. Journal of Pediatrics, 2005; 146: 171-176.
26. Rodbard HW, Green AJ, Fox KM, Grandy S, Shield Study Group. Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses. Diabetes Research & Clinical Practice, 2010; 87: 360-365.
27. Kim E, Gupta S, Bolge S, Chen CC, Whitehead R, Bates JA. Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey. Journal of Medical Economics, 2010; 13: 185-192.
28. Gutierrez-Maldonado J, Caqueo-Urizar A. Effectiveness of a psycho-educational intervention for reducing burden in Latin American families of patients with schizophrenia. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation, 2007; 16: 739-747.
29. Moss L, Crane PB. Exploring polypharmacy in elderly women after myocardial infarction. Journal of Women and Aging, 2010; 22: 22-33.
30. World Health Organization. Diagnosis and Management of Adverse Drug Reactions. Geneva: World Alliance for Patient Safety, 2007.
31. Thomas P. The stable patient with schizophrenia - from antipsychotic effectiveness to adherence. European Neuropsychopharmacology, 2007; 17: 115-122.
32. Tjia J, Micco E, Armstrong K. Interest in breast cancer chemoprevention among older women. Breast Cancer Research and Treatment, 2008; 108: 435-453.
33. Ow R. Burden of care and childhood cancer: experiences of parents in an Asian context. Health and Social Work, 2003; 28: 232-240.
34. Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario, Canada. Supportive Care in Cancer, 2006; 14: 1077-1085.
35. Zucca A, Boyes A, Girgis A, Hall A, Newling G. Travelling all over the countryside: travel-related burden and financial difficulties reported by cancer patients in New South Wales and Victoria. Australian Journal of Rural Health, 2011; 19: 298-305.
36. Nicholl D, Akhras KS, Diels J, Schadrack J. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective. Current Medical Research and Opinion, 2010; 26: 943-955.
37. Vijan S, Hayward RA, Ronis DL, Hofer TP. Brief report: the burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. Journal of General Internal Medicine, 2005; 20: 479-482.
38. Ziaian T, Sawyer MG, Reynolds KE et al. Treatment burden and health-related quality of life of children with diabetes, cystic fibrosis and asthma. Journal of Paediatrics and Child Health, 2006; 42: 596-600.
39. Brod M, Cobden D, Lammert M, Bushnell D, Raskin P. Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health & Quality of Life Outcomes, 2007; 5: 8.
40. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Supportive Care in Cancer, 2008; 16: 791-801.
41. Haugstvedt A, Graue M, Rokne B, Wentzel-Larsen T. Perceived family burden and emotional distress: similarities and differences between mothers and fathers of children with type 1 diabetes in a population-based study. Pediatric Diabetes, 2011; 12: 107-114.
42. Martire LM, Gildengers AG, Karp JF, Reynolds CF, Schulz R, Whyte EM. Treatment of late-life depression alleviates caregiver burden. Journal of the American Geriatrics Society, 2010; 58: 23-29.
43. de Kraker J, Graf N, Van Tinteren H et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet, 2004; 364: 1229-1235.
44. Wysocki T, Gavin L. Paternal involvement in the management of pediatric chronic diseases: associations with adherence, quality of life, and health status. Journal of Pediatric Psychology, 2006; 31: 501-511.
45. Benner JS, Chapman RH, Petrilla AA, Tang SSK, Rosenberg N, Schwartz JS. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy. American Journal of Health-System Pharmacy, 2009; 66: 1471-1477.
46. Robertson TA, Cooke CE, Wang J, Shaya FT, Lee HY. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. American Journal of Managed Care, 2008; 14: 710-716.
47. Yoon J, Adams JL, Ganz PA et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Research and Treatment, 2008; 108: 69-77.
48. Olinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatric Diabetes, 2009; 10: 142-148.
49. World Health Organization. Adherence to long-term therapies: evidence for action. 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence:full_report.pdf (accessed 11 May 2012).
50. Australian Department of Health and Ageing. Evaluation of the DAA/PMP Programs. 2010. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/5B1B138DA00BB9C7CA2578150083984E/&File/DAA%20PMP%20Report.pdf (accessed 11 May 2012).
51. Fried TR, Bradley EH, Towle VR. Assessment of patient preferences: integrating treatments and outcomes. The Journals of Gerontology: Series B: Psychological Sciences and Social Sciences, 2002; 57B: S348-S354.